78 related articles for article (PubMed ID: 28099265)
21. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
Lecouvet FE; Geukens D; Stainier A; Jamar F; Jamart J; d'Othée BJ; Therasse P; Vande Berg B; Tombal B
J Clin Oncol; 2007 Aug; 25(22):3281-7. PubMed ID: 17664475
[TBL] [Abstract][Full Text] [Related]
22. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
[TBL] [Abstract][Full Text] [Related]
23. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F
Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
25. Quantitative bone metastases analysis based on image segmentation.
Erdi YE; Humm JL; Imbriaco M; Yeung H; Larson SM
J Nucl Med; 1997 Sep; 38(9):1401-6. PubMed ID: 9293797
[TBL] [Abstract][Full Text] [Related]
26. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
[TBL] [Abstract][Full Text] [Related]
27. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
[TBL] [Abstract][Full Text] [Related]
28. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
[TBL] [Abstract][Full Text] [Related]
29. [Prospective study to assess the clinical efficacy of bone scintigraphy--methodology and some preliminary results].
Akiyama Y; Yui N; Matsumoto T; Iinuma T; Tateno Y; Yamasaki T; Ishikawa T; Nakajima T; Machida K; Nishikawa J
Radioisotopes; 1984 Feb; 33(2):65-72. PubMed ID: 6739859
[TBL] [Abstract][Full Text] [Related]
30. Correlation between BMD and bone scintigraphy in patients with prostate cancer.
Perk H; Yildiz M; Kosar A; Cerci S; Soyupek F; Ozorak A; Dilmen C
Urol Oncol; 2008; 26(3):250-3. PubMed ID: 18452814
[TBL] [Abstract][Full Text] [Related]
31. Response evaluation of bone metastasis in prostate cancer: Preliminary comparison of computerized bone scan index versus standardized clinical criteria.
Petersen LJ; Gade M; Fonager RF; Albertsen S; Fledelius J; Ejlersen JA; Christensen MH; Aleksyniene R; Zacho HD
Hell J Nucl Med; 2021; 24(1):2-9. PubMed ID: 33866333
[TBL] [Abstract][Full Text] [Related]
32. Complimentary role of FDG-PET imaging and skeletal scintigraphy in the evaluation of patients of prostate carcinoma.
Tiwari BP; Jangra S; Nair N; Tongaonkar HB; Basu S
Indian J Cancer; 2010; 47(4):385-90. PubMed ID: 21131750
[TBL] [Abstract][Full Text] [Related]
33. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
34. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
[TBL] [Abstract][Full Text] [Related]
35. The prediction of pouch of Douglas obliteration using offline analysis of the transvaginal ultrasound 'sliding sign' technique: inter- and intra-observer reproducibility.
Reid S; Lu C; Casikar I; Mein B; Magotti R; Ludlow J; Benzie R; Condous G
Hum Reprod; 2013 May; 28(5):1237-46. PubMed ID: 23482338
[TBL] [Abstract][Full Text] [Related]
36. Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
Bombardieri E; Setti L; Kirienko M; Antunovic L; Guglielmo P; Ciocia G
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):381-99. PubMed ID: 26337240
[TBL] [Abstract][Full Text] [Related]
37. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT.
Zacho HD; Manresa JAB; Aleksyniene R; Ejlersen JA; Fledelius J; Bertelsen H; Petersen LJ
EJNMMI Res; 2017 Dec; 7(1):1. PubMed ID: 28058659
[TBL] [Abstract][Full Text] [Related]
38. Only moderate intra- and inter-observer agreement between radiologists and surgeons when grading blunt paediatric hepatic injury on CT scan.
Nellensteijn DR; ten Duis HJ; Oldenziel J; Polak WG; Hulscher JB
Eur J Pediatr Surg; 2009 Dec; 19(6):392-4. PubMed ID: 19899038
[TBL] [Abstract][Full Text] [Related]
39. Repeated biopsies in patients with prostate cancer on active surveillance: clinical implications of interobserver variation in histopathological assessment.
Thomsen FB; Marcussen N; Berg KD; Christensen IJ; Vainer B; Iversen P; Brasso K
BJU Int; 2015 Apr; 115(4):599-605. PubMed ID: 24903618
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
